腹腔镜D2淋巴结清扫联合完整胃系膜切除治疗局部进展期胃上部癌的近期与远期疗效
该回顾性研究纳入242例局部进展期胃上部癌患者,比较腹腔镜D2淋巴结清扫联合完整胃系膜切除与单纯D2清扫的近期和远期疗效。
要点
- 联合完整胃系膜切除可减少术中出血并提高淋巴结清扫数目。
- 联合组术后排气、进食及住院时间更短,恢复更快。
- T4a患者从联合完整胃系膜切除中获显著生存获益。
核心结论
- 与单纯D2淋巴结清扫相比,腹腔镜D2淋巴结清扫联合完整胃系膜切除治疗局部进展期胃上部癌在淋巴结清扫更彻底、出血更少和术后恢复更快方面具有显著优势。
- T4a期患者从联合完整胃系膜切除中获益尤为显著,长期生存结局明显改善。
研究设计与样本
- 回顾性分析2014年1月至2019年8月福建莆田市第一医院收治的242例接受腹腔镜根治性胃切除术的局部进展期胃上部癌患者的临床资料。
- 比较D2淋巴结清扫联合完整胃系膜切除组与单纯D2淋巴结清扫组的近期和远期结局。
主要发现
- 联合组术中出血量显著少于对照组(89.43 ± 74.66 mL vs 145.70 ± 63.20 mL,P < .001)。
- 联合组淋巴结清扫数目显著多于对照组(42.91 ± 17.29 vs 37.10 ± 14.98,P = .008)。
- 联合组术后恢复时间更短:首次排气3 [2-3] vs 3 [3-3]天(P < .001),首次流质饮食8 [7-8] vs 8 [7-9]天(P = .021),住院时间14 [12-16] vs 15 [14-15]天(P = .035)。
- 亚组分析显示T4a期患者中联合组总生存和无病生存均显著获益(P = .014)。
临床怎么用
- 对于局部进展期胃上部癌,尤其是T4a期患者,可考虑在腹腔镜D2淋巴结清扫基础上联合完整胃系膜切除以改善肿瘤学结局和术后恢复。
局限性
- 本研究为单中心回顾性分析,证据等级有限。
- 总体生存差异未达统计学显著性(P = .067),需进一步研究验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The purpose of this article is to evaluate the short-term and long-term efficacy of laparoscopic D2 lymphadenectomy plus complete mesogastrium excision in treating locally advanced upper gastric cancer. METHODS: We conducted a retrospective analysis of clinical data from 242 patients with locally advanced upper gastric cancer who underwent laparoscopic radical gastrectomy at the First Hospital of Putian in Fujian Province between January 2014 and August 2019. Short- and long-term outcomes were compared between the 2 groups. RESULTS: The D2 lymphadenectomy plus complete mesogastrium excision group demonstrated significantly less intraoperative blood loss (89.43 ± 74.66 mL vs 145.70 ± 63.20 mL, P < .001), a higher lymph node yield (42.91 ± 17.29 vs 37.10 ± 14.98, P = .008), and shorter postoperative recovery times (first flatus: 3 [2-3] vs 3 [3-3] days, P < .001; first liquid diet: 8 [7-8] vs 8 [7-9] days, P = .021; hospital stay: 14 [12-16] vs 15 [14-15] days, P = .035). Subgroup analysis showed significant overall survival and disease-free survival benefits for patients with stage T4a in the D2 lymphadenectomy plus complete mesogastrium excision group (P = .014 for both). CONCLUSION: Compared with D2 lymphadenectomy, laparoscopic D2 lymphadenectomy plus complete mesogastrium excision for locally advanced upper gastric cancer demonstrates significant advantages, including more extensive lymph node dissection, reduced blood loss, and faster postoperative recovery. Although no significant difference in overall survival was observed (P = .067), the D2 lymphadenectomy plus complete mesogastrium excision approach achieved lower local recurrence rates and superior 5-year disease-free survival. Notably, patients with stage T4a derived particular benefits from D2 lymphadenectomy plus complete mesogastrium excision, showing significantly improved long-term survival outcomes.
引用
- Liu F, Xu Y, Wu H, et al. Short-term and long-term efficacy of laparoscopic D2 lymphadenectomy combined with complete mesogastrium excision for locally advanced upper gastric cancer. Surgery. 2025. PMID: 41365720. doi:10.1016/j.surg.2025.109932
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。